Arbital Health Secures $31 Million in Series B Funding to Propel Progress in Value-Driven Healthcare Risk Agreements
Arbital Health Secures $31 Million in Series B Funding
Arbital Health, a leading healthcare technology company, has announced the successful completion of a $31 million Series B funding round, led by Valtruis, in July 2025. This investment is set to propel Arbital Health's growth and transform the understanding and management of financial and performance risk in the healthcare system.
The funding will be primarily used to expand Arbital Health's payer and provider-facing capabilities, accelerate the monitoring and management of value-based care contracts, and grow its actuarial team. This investment will also enhance Arbital Health's AI-powered platform, which centralizes fragmented data, automates contract reconciliation, and supports value-based care performance decision-making.
Mike Spadafore, Managing Director at Valtruis, expressed his support for Arbital Health's team, stating, "Arbital Health's team has a deep understanding of the complexities in value-based care, and their AI-powered platform is uniquely positioned to address these challenges."
Since its founding in 2024 by Travis May and Brian Overstreet, Arbital Health has built a client roster of over 40 payers, providers, and integrated delivery networks. The company has onboarded more than 600,000 patient lives to its platform and has strengthened partnerships with healthcare organizations such as HarmonyCares, Aligned Marketplace, Arkos Health, and Complete Health.
Arbital Health's mission is to build the critical infrastructure for the market, powered by leading actuarial expertise and AI-driven technology. The company aims to help clients make smarter decisions, reduce financial risk, and improve patient outcomes. With this new funding, Arbital Health will broaden its reach to more payers, providers, digital point solutions, and integrated delivery networks.
The Series B funding round also saw participation from Transformation Capital, Shaper Capital, and Healthy Ventures. This investment will not only accelerate Arbital Health's mission to transform how the industry manages value-based care but also enhance its benchmarking capabilities, providing more actionable, data-driven insights.
In conclusion, Arbital Health is actively scaling its infrastructure, enhancing its technology, and expanding its expert teams to accelerate the adoption and success of value-based care contracts following its significant Series B investment. This move is set to revolutionize the healthcare industry, reducing administrative complexity and financial risk while improving patient outcomes and supporting sustainable financial performance in value-based care contracts.
- Arbital Health's AI-powered platform, funded by $31 million from Series B investment, will not only support value-based care performance decision-making but also strengthen its benchmarking capabilities, offering more actionable, data-driven insights in the realm of health-and-wellness technology.
- With the motivation from Series B funding of $31 million, alongside Transformation Capital, Shaper Capital, and Healthy Ventures, Arbital Health plans to delve deeper into the science of financial risk management in the healthcare system, aiming to improve patient outcomes and promote sustainable financial performance in value-based care contracts, leveraging its cutting-edge technology.
